Ligands for FPR class receptors that induce a host immune response to a pathogen or inhibit HIV infection

Details for Australian Patent Application No. 2000227546 (hide)

Owner The Government of the United States of America as represented by the Secretary, Department of Health and Human Services

Inventors Li, Bao Qun; Oppenheim, Joost J; Murphy, Philip; Gong, Wang-Hua; Le, Yingying; Rogers, Thomas J; Wang, JiMing

Agent Cullen & Co

Pub. Number AU-B-2000227546

PCT Pub. Number WO01/57074

Filing date 4 February 2000

Wipo publication date 14 August 2001

Acceptance publication date 30 August 2007

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

A61K 35/12 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Materials from mammals or birds

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/16 (2006.01) Peptides having more than 20 amino acids

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/566 (2006.01) Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

Event Publications

12 June 2003 Section 223 Application Allowed

  The Govt. of the United States of America, as represented by the Dept. of Health and Human Services The time in which to enter the National Phase has been extended to 04.10.2002 . Address for service in Australia - Cullen & Co 239 George Street Brisbane QLD 4000 2001

6 May 2004 Corrigenda

  Extensions of Time, Section 223 - Applications Allowed - Section 223(2) Under the name The Govt. of the United States of America, as represented by the Dept. of Health and Human Services, Application No. 2000227546, correct the name to read, The Government of the United States of America, as represented by the Secretary of Health and Human Services.

30 August 2007 Application Accepted

  Published as AU-B-2000227546

6 December 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2000227559-CARTON AND CARTON BLANK

2000227499